Treatment of stage one pure ovarian dysger minoma in young women. A case report and re view of the literature;Il trattamento del disgerminoma puro dell'ovaio al i stadio nelle siovani donne

Minerva Ginecologica

Volumn 51, Issue 1-2, 1999, Pages 27-30

  Mazza, D ^a   Pozzi, M ^b   Sedati, A ^b   Vocaturo, G ^b  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b NONE

Author keywords

Dysgerminoma diagnosis; Dysgerminoma surgery; Ovarian neoplasms

Indexed keywords

ADULT; CANCER STAGING; CASE REPORT; DYSGERMINOMA; FEMALE; HUMAN; LYMPHADENECTOMY; METHODOLOGY; OVARIECTOMY; OVARY TUMOR; PATHOLOGY; REVIEW;

ADULT; DYSGERMINOMA; FEMALE; HUMANS; LYMPH NODE EXCISION; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARIECTOMY;

EID: 0032602141     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Krepart G, Smith JP, Rutledge F, Delclos L. The treatment for dysgerminoma of the ovary. Cancer 1978:41:986-90.
2. Tallerman A. Germ cell tumors of the ovary. In Blanstein A, editor. Pathology of the female genital tract. New York: Ed. Springer-Verlag, 1977:527-85.
3. Gordon A, Lipton D, Woodruff JD. Disgerminoma: a re view of 158 cases from the Emil Novak ovarian tumor registry. Obstet Gynecol 1981;58:497-504.
4. Gallion HH, Van Nagell JR, Donaklson ES, Powell DE. Ovarian dysgerminoma report of 7 cases and review of the literature. Am J Obstet Gynecol 1988; 158:591-5.
5. Dilhuydy JH, Lagarde P, Chauvergne J, Mongodin B, Dilhuydy MH et al. Le dysgerminome ovarian pur. Bilan d'une experience et definition d'une strategie therapeutique. Bull Cancer 1990;77:213-24.
6. Freel JH, Cassir JF, Pierce VK, Woodruff J, Lewis J. Dysgerminoma of the ovary. Cancer 1979;43:798-805.
7. Asadourian LA, Taylor HB. Dysgerminoma. An analy sis of 105 cases. Obstet Gynecol 1969:33:370-9.
8. Thomas GM, Dembo AJ, Hacker NF, De Petrillo AD. Current therapy for dysgerminoma of the ovary. Obstet Gynecol 1987;70:268-75.
9. Gershenson DM, Wharton JT, Klinerc Larson DM, Kananagh JJ, Rutledge FN. Chemotherapeutic com plete remission in patients with metastatic ovarian dy sgerminoma. Potential for cure and preservation. Cancer 1986:58:2594-9.
10. Javanery G, Lifschez A, Valle J. Pregnancy following re moval of and long term chemotherapy for ovarian ma lignant teratoma. Obstet Gynecol 1983;61:85-95.
11. Vriesendorp P, Aalders SG, Sleijfer DT, Willemse PHB, Bouma J, Mulder NH. Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine and bleomycin (PVB). Cancer Treat Rep 1984;68:779-81.
12. Taylor MH, De Petrillo AD, Turner AR. Vinblastine, Bleomycin and Cisplatin in malignant germ cell tu mors of the ovary. Cancer 1985;53:1341-9.
13. Einhorn LH, Williams SH. Chemotherapy of dissemi nated seminoma. Cancer Clin Trials 1980;3:307-13.
14. Awais GM. Dysgerminoma and serum lactic dehydro genase levels. Obstet Gynecol 1983;61:99-101.
15. Awais GM. Carcinoma of the ovary and serum lactic dehydrogenase levels. Surg Obstet Gynecol 1978; 46:893-5.
16. Sheiko MC, Hart WR. Ovarian germinoma (dysgermi noma) with elevated serum lactic dehydrogenase. Case report and review of the literature. Cancer 1982;49: 994-8.
17. Dgani R, Shoham Z, Czernobilsky B, Kaftori A, Borenstein R, Lancet M. Lactic dehidrogenase. alkaline phosphatase and human chorionic gonadotropin in a pure ovarian dysgerminoma. Gynecol Oncol 1988; 30:44-50.